Kirsten Arndt

This inventor holds 29 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Gmbh & Co Kg, Orexo Ab. Active years: 2006-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kirsten Arndt. Retrieved from https://idiyas.com/inventor/kirsten-arndt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 8)

% Patents Active = 86.2

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 8.4

ph-index = 6

Forward Citations = 165(Granted Patents)

Location History:

Biberach, DE (2006 - 2011)
Ravensburg, DE (2011 - 2015)

Company Filing History:

20 out of 1,562

Boehringer Ingelheim International Gmbh

patents

6 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

Years Active: 2006-2015

Loading Chart...

Areas of Expertise:

Anti-Inflammatory Agents

CGRP Antagonists

Pharmaceutical Compositions

Piperidine Compounds

Carboxamides

Imidazole Derivatives

Medicinal Chemistry

Alkyne Compounds

MCH Antagonistic Activity

Synthesis Processes

Selected Antagonists

Drug Development

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9040565 - 1H-benzimidazole-5-carboxamides as anti-inflammatory agents (2015-05-26),

2. 8921405 - Compounds (2014-12-30),

3. 8916599 - 1H-benz imidazole-5-carboxamides as anti-inflammatory agents (2014-12-23),

4. 8703796 - 3H-imidazo [4, 5-B] pyridine-6-carboxamides as anti-inflammatory agents (2014-04-22),

5. 8598190 - 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents (2013-12-03),

6. 7985747 - Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions (2011-07-26),

7. 7897603 - Selected CGRP-antagonists, processes for preparing them and their use as pharmaceutical compositions (2011-03-01),

8. 7858622 - Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions (2010-12-28),

9. 7807666 - CGRP antagonists (2010-10-05),

10. 7700598 - Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions (2010-04-20),

11. 7700589 - CGRP antagonists (2010-04-20),

12. 7696209 - CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions (2010-04-13),

13. 7696196 - Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions (2010-04-13),

14. 7696195 - Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions (2010-04-13),

15. 7625886 - Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions (2009-12-01),

Title: Kirsten Arndt: A Pioneer in Technological Innovation

Introduction:

Kirsten Arndt, a visionary inventor based in Biberach, Germany, is renowned for his relentless passion for innovation and his commitment to making a positive impact on society through his groundbreaking inventions.

Latest Patents:

Arndt, with an impressive portfolio of 29 patents, recently unveiled his latest creation - '1H-benzimidazole-5-carboxamides as anti-inflammatory agents'. These compounds, designed to inhibit the activity of the MAPEG family, show promising results in the treatment of inflammation and cancer.

Career Highlights:

Having contributed significantly to the field of technology, Arndt has left an indelible mark on companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. His innovative solutions have revolutionized the pharmaceutical industry.

Collaborations:

Arndt's collaborative efforts with esteemed colleagues like Dirk Stenkamp and Henri Doods have further propelled his inventions to new heights. Together, they have pioneered advancements in the realm of medicinal chemistry and pharmaceuticals.

Conclusion:

In conclusion, Kirsten Arndt's unwavering dedication to pushing the boundaries of innovation and his transformative impact on society solidify his position as a true luminary in the world of technology. His inventive spirit continues to drive progress and inspire future generations of inventors.

Profile summary based on public USPTO records.